AL
CSX icon

Aspiriant LLC’s CSX Corp CSX Stock Holding History

Aspiriant LLC’s Portfolio CSX Stock Details CSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,643
Closed -$320K – 296
2024
Q1 		$320K Sell
8,643
-6
-0.1% -$219 0.01% 237
2023
Q4 		$300K Sell
8,649
-628
-7% -$20K 0.01% 240
2023
Q3 		$285K Buy
9,277
+2,185
+31% +$69.2K 0.01% 231
2023
Q2 		$242K Hold
7,092
– – 0.01% 252
2023
Q1 		$212K Hold
7,092
– – 0.01% 261
2022
Q4 		$220K Buy
+7,092
New +$213K 0.01% 250
2016
Q3 		– Sell
-49,887
Closed -$543K – 188
2016
Q2 		$543K Buy
+49,887
New +$434K 0.05% 134

Other funds holding CSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Aspiriant LLC's CSX Position: Q2 2024 in Review

Aspiriant LLC sold out of CSX Corp (CSX) in Q2 2024, closing a stake of 8,643 shares — an estimated $320K sold.

Aspiriant LLC first reported a position in CSX in Q2 2016 and held it in 7 quarters. The position peaked at $543K in Q2 2016. 1,658 funds tracked by Wall St. Rank hold CSX as of Q2 2024.

  • Aspiriant LLC reported no remaining CSX Corp position as of Q2 2024 after selling out during the quarter.
  • Aspiriant LLC sold 8,643 CSX Corp shares in Q2 2024, an estimated $320K.
  • Aspiriant LLC first reported a position in CSX Corp in Q2 2016 and held it in 7 quarters.
  • Aspiriant LLC's CSX Corp position peaked at $543K in Q2 2016.
  • 1,658 funds tracked by Wall St. Rank held CSX Corp as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.